aibioCybin Inc. (now Helus Pharma) files Form 25 to leave NYSE American
Tickers HELP
The January 2, 2026 filing covers the company's common shares. It relies on the SEC rule for a voluntary withdrawal by the issuer.
Key facts
- Company
- Helus Pharma Inc. (NEO: HELP)
- News type
- Listings
- Primary source
- Helus Pharma Inc. 25 (2026-01-02)
Cybin Inc. (now Helus Pharma Inc.) filed a Form 25 with the SEC on January 2, 2026. A Form 25 is the notice that a class of securities is being removed from listing and registration on a national exchange. The filing names NYSE American LLC as the exchange and the company's common shares as the class.
The company marked the box for 17 CFR 240.12d2-2(c). That rule covers a voluntary withdrawal by the issuer, meaning the company itself asks to end the listing. In the form, Cybin certifies that it has reasonable grounds to believe it meets all of the requirements for filing the Form 25. It also states that it has complied with the rules of the exchange and the requirements of the SEC rule that govern voluntary withdrawal.